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Background
Peripheral arterial disease (PAD) is a relatively common manifestation of systemic atherosclerosis affecting 12-20% of patients over 60 years of age. 1,2 In the general population the average incidence is 26/10,000 men and 12/10,000 women; about 25% the incidence of coronary artery disease. PAD is more prevalent in patients who smoke cigarettes, those with diabetes mellitus and hypertensive patients. The primary symptom of PAD is intermittent claudication (painful walking) which is related to the impairment of muscle blood flow due to arterial stenoses at various levels in the peripheral arterial circulation. Patients with PAD remain relatively stable for long periods of time. At five years after the onset of claudication, 75% of patients have stable symptoms while only 25% require some form of mechanical revascularization therapy. 3,4 Thus, the majority of patients with PAD have chronic symptoms which limit their ability to walk and result in greatly diminished exercise capacity as demonstrated on treadmill testing. 5, 6 The therapeutic options available to PAD patients are limited. Vascular surgery and peripheral vascular angioplasty are reserved for patients with more severe symptoms or for limb salvage and cannot be applied to all patients with more diffuse atherosclerosis. In addition, unlike patients with coronary artery disease where many effective drugs are available to improve exercise capacity, patients with PAD have fewer medical therapeutic options. Pentoxifylline, a haemorheologic agent that decreases blood viscosity and alters red blood cell rigidity, has been shown to result in a 50-100% improvement in treadmill walking ability especially in patients with moderately severe disease.8 Careful analysis of all the clinical trials using this agent suggest a modest effect on exercise performance.9
Vasodilators have not been demonstrated to either increase leg blood flow, improve exercise capacity, or alleviate symptomsl° Carnitine supplementation has been shown to improve exercise performance in patients with PAD,&dquo; but this form of therapy is currently experimental. Thus, many patients with PAD 3.5 ml/kg/min, resting oxygen consumption, V02) , 17 most of the improvement in the PAD patient is related to the exercise conditioning programme and usually occurs at a lower level of initial exercise capacity (5 METS). The exercise prescription in the PAD patient is derived from the workload at which moderate claudication occurs and does not correspond to the heart rateoxygen consumption (V02) relationship used to determine the intensity of exercise in cardiac patients. Most PAD patients are unable to exercise to a high heart rate or oxygen consumption to utilize this type of exercise prescription. A comparison between the exercise conditioning effects observed in cardiac and PAD patients during submaximal and peak exercise is shown in Table 1 . After conditioning, during submaximal exercise, both groups of patients develop decreases in heart rate, heart ratesystolic blood pressure product (an index of myocardial oxygen consumption), minute ventilation and respiratory exchange ratio (RER) which is VCOiV02. Decreases in heart rate and blood pressure indicate improved exercise haemodynamics after training, while a decrease in RER indicates a greater utilization of fat metabolism which indicates a diminished metabolic burden at a given level of exercise. The ischaemic thresholds for either angina in the cardiac patient or claudication in the PAD patient increase, thereby allowing more work to be performed before symptoms occur or are limiting.
Variable effects on blood pressure and blood lactate concentration have been reported after training in the PAD patient and are probably related to a lack of data obtained during submaximal exercise. The major difference observed appears to be in V02; whereas cardiac patients usually maintain the same V02 at a given workload, the PAD patient consumes less oxygen. This decrease in submaximal VO2 remains unexplained but may relate to improved efficiency of walking as noted in some cardiac patients. 18 At peak exercise there are many differences in the training effects between cardiac and PAD patients. These differences are due to the inability of the PAD patient to reach a near maximal V02 at the time of severe claudication. 5,6 While the cardiac patient is able to attain a near maximal cardiovascular response to progressive exercise, as demonstrated by a high VO~, a RER > 1.05, a high heart rate near age-predicted maximums and a high blood lactate concentration (>4.0 mM), the PAD patient usually cannot stimulate the cardiovascular system to this degree due to claudication limiting the exercise. After training the PAD patient can extend the time of exercise to higher workloads and thereby increase heart rate, blood pressure, minute ventilation and RER at peak exercise. Both cardiac and PAD patients do increase their peak exercise capacity as well as the time of pain-free walking (PFWT). Thus, despite the differences in responses between these two groups of patients, both the PAD and cardiac patient can expect to obtain an improvement in submaximal and peak exercise performance from regular physical exercise training. The primary goal of an exercise conditioning programme in PAD patients is to increase exercise performance in order to relieve disability.
Methods of exercise testing and training Patient eligibility
Most patients with claudication-limiting walking are eligible for exercise conditioning. The severity of the disease does not appear to alter the training response. Patients with rest pain have been shown to improve as much as those with mild to moderate disease. 19 Disease location (proximal, distal, unilateral or bilateral), as well as associated coronary artery disease, also does not appear to limit the ability to improve from exercise conditioning. 19,20 However, patients with gangrene, active ischaemic ulcers, progressive rest pain and ankle systolic pressure less than 40mmHg should be excluded.
Haemodynamic evaluation
An assessment of the severity of the peripheral arterial disease should be performed at rest and immediately after exercise by measurement of an ankle and arm systolic blood pressure with a Doppler ultrasonic device. The ratio of ankle to arm systolic blood pressure at rest is <0.95 in patients with PAD.2 At rest, this ratio is an index of the severity of the underlying vascular disease2l although it is a poor predictor of exercise capacity.5 With exercise, the systolic pressure in the ankle typically falls in patients with PAD,22 in association with the symptoms of claudication.
Assessment of functional capacity
The ability to obtain an accurate reproducible measurement of the patient's walking ability is critical in determining the outcome of the programme as well as to derive an effective exercise prescription. Since most PAD patients experience their symptoms with walking, treadmill testing has been used to assess their functional limitations. The majority of studies have used a constant load test where most patients stop after reaching a maximal level of claudication. The time (or distance) at which claudication begins, and the maxima claudication-limited walking time are recorded. There are many problems with this type of test including lack of reproducibility,' 7 lack of information on submaximal and peak performance including V02 and also limited ability to assess improvement after a training programme, especially if the patient does not reach a claudication-limiting endpoint after training. Recently, a graded treadmill exercise test protocol was developed specifically for PAD patients. Walking speed was maintained at 2mph while the grade was increased 3.5% every three minutes. This resulted in small increments in V02 with each change in workloadan important factor in these severely limited patients. Maximal walking time, time to onset of claudication and peak and submaximal V02 can be accurately and reproducibly measured. This protocol was used to document improvements in peak exercise performance in PAD patients after training.23 An important aspect of the testing is the utilization of a claudication scale where pain severity was assessed every 30 seconds using a perceived pain scale of 1-5 where 1 = no pain, 2 = onset of pain, 3 = mild, 4 = moderate and 5 = maximal pain requiring cessation of exercise. In addition to objective, physiologic testing, an assessment of the impact of the disease on daily activities and quality of life would determine the ultimate benefit of exercise conditioning in PAD patients. Recently, a walking impairment questionnaire was developed to assess the effect of interventions on the walking ability of patients with PAD . 24 Self-reported walking activity was highly correlated to peak walking time on treadmill testing. The assessment of walking speed, distance and symptoms enabled a functional assessment of daily activities in these claudication-limited patients.
Exercise training
Various types of exercise have been used in exercise conditioning programmes in patients with PAD. These include 'dynamic' leg exercise, isotonic exercise of specific muscle groups, bicycle exercise, stair climbing, treadmill walking and unsupervised community walking. Since walking is the limited activity in PAD patients, treadmill walking exercise is the main component of the exercise programme. A treadmill is often used since workload can be reliably adjusted to produce claudication and readjusted as the patient improves to re-establish a training stimulus that will continue to produce symptoms.
Most exercise sessions last 30-60 minutes, occur three times a week and last for 3-6 months. The majority of programmes are supervised to encourage compliance, and telemetry ECG monitoring is used to monitor for possible cardiac complications, especially as the patients are able to perform more strenuous exercise.
On entry into the conditioning programme, a PAD patient's exercise prescription is individualized based on the level of exercise limitation resulting from claudication on an initial graded treadmill exercise test. After a five minute warm-up period, patients initially walk at a low speed (1.5-2.0mph) with 0% grade on the treadmill until they develop moderately severe claudication. They step off the treadmill and rest until the claudication subsides and then resume the exercise. Exercise and rest sessions are repeated throughout each training session with the total exercise duration being recorded. After a patient can walk for 8-10 minutes, the speed and grade are increased. This form of interval training is continued throughout the duration of the programme and patients usually walk for a total of 30 minutes during each exercise session. All exercise sessions are followed by a cool-down period lasting five minutes or longer depending on the individual's rate of recovery after exercise.
Community walking is also encouraged on days when supervised exercise is not performed.
Outcomes of exercise conditioning
Over the last 24 years, 26 trials of exercise conditioning in patients with PAD have been performed. Although all these studies demonstrate an increase in total treadmill exercise time, as well as an increase in walking time prior to claudication (pain-free walking time), most of these studies did not have adequate controls. Nine controlled studies have been performed 23,25-32 which confirm this increase in exercise capacity. Eight of these studies are listed in Table 2 with information about the design, sample size, testing and training formats and the extent of improvement. The majority of these studies utilized a constant load treadmill protocol. The improvement in PFWT ranged from 87% to 250% with an average of 152%. The total walking time increased from 67% to 183% with an average of 121%. Thus, exercise conditioning resulted in an ability to sustain walking exercise for longer durations with a longer time until claudication pain. Exercise conditioning also resulted in improvements in peak exercise performance when a graded treadmill protocol was used.23 Patients were able to exercise to a higher workload after training with a 30% increase in peak V02. There was an accompanying 123% increase in peak walking time and a 165% increase in PFWT. Thus, patients were able to perform activities of higher intensity which could greatly improve their ability to perform more strenuous activities at home. During submaximal exercise there were associated relative decreases in heart rate, minute ventilation, RER and V02.
In addition to the exercise performance studies demonstrating improvement in walking ability after exercise conditioning in PAD patients, there was also questionnaire-derived information documenting enhanced walking ability in the home setting.24 Patients increased their walking distance and speed in activities of daily living as well as a reduction in their claudication symptoms. Thus, exercise conditioning resulted in significant improvements in all measured variables of exercise performance.
Mechanisms of improvement
Although it is clear that exercise conditioning results in improvement in exercise capacity in PAD patients, the mechanisms responsible for this improvement have not been determined.
Several different mechanisms have been suggested ( Table 3 ) but no definite mechanism has yet been established.
Since muscle ischaemia resulting from decreased muscle blood flow is the cause of claudication during exercise, perhaps exercise conditioning results in improved blood flow thereby reducing the severity of claudication. Several studies have shown some increase in peak leg blood flow after exercise conditioning in PAD patients. 23 Table 3 Potential mechanisms of improvement Table 2 Controlled exercise conditioning studiesperipheral arterial disease (pk WT = peak walking time; PFWT = pain-free walking time; Ex = exercise group; C = nonexercising controls.)
Patients with PAD have also been reported to have similar adaptations in skeletal muscle oxidative metabolism. 28, 29, 38 In addition, some patients with PAD have abnormally high levels of plasma short-chain acylcarnitine which may reflect altered skeletal muscle metabolism due to chronic muscle ischaemia.39 Exercise conditioning results in a decrease in these short-chain acylcarnitines,23 and patients who had the greatest response to training also had the greatest reduction in the plasma short-chain acylcarnitine concentration.
Thus, muscle metabolic adaptations may play an important role in the exercise conditioning response in PAD patients and allow more effective extraction and utilization of oxygen.
Skeletal muscle strength and endurance have been demonstrated to be diminished in patients with PAD.4° Part of the improvement in walking ability may relate to increased muscle strength and enhanced resistance to fatigue. No current information is available concerning this potential mechanism.
Finally, alterations in gait could explain the decrease in V02 during submaximal exercise seen with exercise conditioning in PAD patients.23 To date, no gait analysis studies have been performed in these patients. Alteration in pain perception could also be involved in the improvements seen in the claudication-limited exercise duration seen with training.
Special populations and issues
Although each of the exercise conditioning studies has demonstrated significant improvements in total walking time and PFWT, most of the patients studied were nondiabetic males. Very little information is available on the efficacy of exercise conditioning in women with PAD and claudication. Women with coronary artery disease appear to have poorer rehabilitative outcomes after myocardial infarction compared to men,41 and similar issues need to be addressed in women with PAD. In addition, women with PAD are also more likely to have diabetes mellitus which could modify the training response. In a recent review of the controlled trials of exercise conditioning in PAD, 9 9 only two studies25,26 included diabetics. The associated peripheral neuropathy, occult coronary disease and severity of distal circulatory disease occurring in diabetic patients may influence the expected conditioning responses. Training-induced muscle metabolic effects of exercise conditioning could also be altered by the disturbed metabolic state of the diabetic. At the present time, there is no available information concerning the role of exercise conditioning in the diabetic patient with PAD. Diabetics enrolled in a PAD controlled programme need special attention directed to foot care as well as frequent evaluation of hypoglycaemic therapy, especially if insulin is required. A potential benefit of exercise conditioning in PAD patients with diabetes may be better glycaemic control which may be independent of the amount of improvement in exercise capacity.
The question of the effect of certain drugs on the exercise conditioning response in patients with PAD has not been addressed. In normal subjects, beta-adrenergic blockers have been shown to attenuate the training response42 with the effects being more prominent while the subjects are still taking the drug.43 There appears to be little difference in this regard between selective and nonselective beta-adrenergic blockade. While other studies in normal subjects have not reported an impairment of training with beta-adrenergic blockers, 44,45 there appears to be less evidence of attenuation of training in cardiac patients . 46, 47 The effects of beta-adrenergic blockade on exercise conditioning in PAD patients is unknown. In patients with PAD and mild to moderate claudication, selective and nonselective beta-adrenergic blockade had no effect on the time to onset of claudication and total claudication-limited exercise duration as well as causing no change in calf blood flow and resistance at rest and during exercise.4g Since the training stimulus in PAD patients is moderate claudication pain during exercise and the exercise prescription is based on this symptom and not on heart rate and V02, both of which are affected by beta-adrenergic blockade, no alteration in the training regimen would be expected with these drugs. In patients with more severe claudication, where skin blood flow may be altered, these drugs are best avoided. Similarly, insulindependent diabetic patients with PAD probably should not take beta-adrenergic blockers due to potentially adverse metabolic and haemodynamic effects, regardless of potential limitations on the exercise conditioning response.
The role of combined drug therapy and exercise conditioning in the enhancement of walking performance in PAD patients has not been addressed. As stated earlier, pentoxifylline resulted in a 50-100% increase in total walking time, probably due to its favourable haemorheological effects.' It is unknown whether the pharmacological properties of this drug would enhance the improvements in walking time seen with exercise conditioning. Since exercise training has been shown to reverse most of the abnormal haemorheological effects seen in PAD patients,26 it is unclear whether this drug would contribute any additional benefits.
Carnitine supplementation has been shown to improve walking time in patients with PAD. 11 If the leg muscles of PAD patients are deficient in total carnitine, fatty acid metabolism would be impaired and free carnitine availability would be limiting for maintaining optimal rates of metabolism. Since exercise conditioning alone can normalize some of the abnormalities in plasma carnitine fractions, it is possible that the combination of carnitine supplementation, along with exercise conditioning, would have additive effects on exercise performance. This would be especially true if favourable alterations in muscle metabolism provide the essential mechanism for improvement in walking performance in these patients. To date, this combination has not been investigated. Combined programmes of aggressive atherosclerotic risk factor modification along with exercise conditioning have not been studied in PAD patients. One study utilizing aggressive diet therapy (Pritikin) along with a structured walking programme reported improvement in exercise performance.49 In this study there was an accompanying rise in the ankle/arm systolic blood pressure ratio indicating a reduction in the severity of the arterial occlusive disease. Whether aggressive programmes aimed at smoking cessation, lipid modification with diet and/or drug therapy, tight diabetic control and normalization of blood pressure when combined with exercise conditioning would result in an even greater reduction in symptoms and improvement in walking ability is unknown. These types of programmes may have more of an impact on the future progression of vascular disease with little additional immediate benefits on walking performance.
Finally, the role of exercise conditioning in patients who have undergone either vascular bypass surgery or peripheral angioplasty needs to be addressed. Many patients with PAD who have undergone mechanical interventions are still significantly functionally impaired. Either they have had incomplete revascularization with some persistent claudication, or they are extremely deconditioned due to their prior physical limitations from chronic leg ischaemia. These patients remain ideal candidates for peripheral vascular conditioning. In a recent study comparing exercise conditioning alone, vascular surgery alone and a combination of both surgery and exercise conditioning, an additive effect on both pain-free and total walking times occurred with combination therapy utilizing a constant workload test.32 Exercise conditioning alone resulted in a 44% increase in PFWT and a 51% increase in maximal walking time (MWT). Surgery alone showed a 276% increase in PFWT and a 73% increase in MWT. Finally, a combined approach resulted in a 599% increase in PFWT and a 163% increase in MWT. Similar data, however, are not available for a combination programme of peripheral angioplasty and exercise conditioning. Thus, even after revascularization therapy, patients with PAD will still benefit from an exercise conditioning programme by further improving their functional capacity as well as addressing secondary prevention issues.
Precautions
Exercise conditioning has proven to be a relatively safe intervention in patients with coronary artery disease. A recent review of 167 cardiac rehabilitation programmes involving 51 303 patients with 2 351 916 patient hours of exercise revealed that the incidences of cardiac arrest, nonfatal myocardial infarction and cardiac mortality were low.5° Although there is limited experience in exercise conditioning of large numbers of PAD patients, no significant cardiovascular complications have been reported. Because of potential cardiovascular complications in these patients with significant atherosclerosis, telemetry ECG monitoring is used during exercise training, heart rate is monitored and recorded although not used in the exercise prescription, and blood pressure is also recorded at the beginning and end of each exercise session. Appropriate warm-up and cool-down periods along with flexibility exercises are used to decrease the risk of musculoskeletal injury. In the diabetic patient special precautions are taken to insure proper foot care to avoid distal ischaemic ulceration.
Secondary prevention
There is no current information available concerning the impact of exercise conditioning in PAD patients on the natural history of the vascular disease including disease progression, long-term limb salvage and development of coronary or cerebral vascular disease. Although exercise conditioning in cardiac patients has been shown to have a favourable effect on plasma lipids, especially triglycerides and HDLcholesterol, 51 there are no studies available in PAD patients. Since the primary lipid abnormalities in PAD patients involve an elevation of plasma triglycerides and a low HDLcholesterol level, there is great potential for regular aerobic exercise to cause favourable changes in these lipids, and thereby possibly to affect the vessel wall biology in these patients. The role of exercise conditioning in the long-term modification of other cardiac risk factors, such as control of hypertension, enhanced diabetic control and smoking cessation is unknown.
Summary
Exercise conditioning has been demonstrated to be an extremely effective means of improving claudication-limiting physical activity in patients with PAD. Because of the limited therapeutic options in these patients, exercise conditioning should become a standard form of therapy in all claudication-limited patients. The precise mechanisms for the observed exercise training are still under investigation but factors such as enhanced muscle metabolism and gait adjustments may be involved. Further studies on the impact of exercise training on quality of life and home activity patterns should be performed in order to determine the full extent of the benefits of this intervention in PAD patients.
